Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Reviva Pharmaceuticals Holdings Inc.’s current trading price is -39.57% away from its 52-week high, while its distance from the 52-week low is 954.72%. The stock’s price range during this period has varied between $0.53 and $9.25. The company, active in the Healthcare sector, saw a trading volume of around 0.63 million for the day, considerably higher average daily volume of 0.16 million observed over the last three months.
The current stock price for Reviva Pharmaceuticals Holdings Inc. (RVPH) is $5.59. The stock experienced a significant increase during the last trading session, reaching $6.69 after opening at $6.50. It dipped to a low of $5.21 before ultimately closing at $6.41.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
The market performance of Reviva Pharmaceuticals Holdings Inc. has been somewhat stable. Over the past year, the company’s stock achieved a high of $9.25 on 05/04/23, with the lowest value for the same timeframe being $0.53, recorded on 08/01/22.
How Financial Performance Impacts Market Capitalization
Reviva Pharmaceuticals Holdings Inc. (RVPH) has experienced a quarterly rise of 19.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 118.23M and boasts a workforce of 10 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.16, with a change in price of +1.34. Similarly, Reviva Pharmaceuticals Holdings Inc. recorded 146,045 in trading volume during the last 100 days, posting a change of +31.53%.
How RVPH’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for RVPH stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
RVPH Stock Stochastic Average
As of today, the raw stochastic average of Reviva Pharmaceuticals Holdings Inc. over the past 50 days is 36.35%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 9.41%. Additionally, the Stochastic %K and %D values for the company were 6.77% and 14.04%, respectively, over the past 20 days.
RVPH Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant gain of 31.53% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 29.10%. Over the past 30 days, the price of RVPH has leaped by -20.14%. And in the last five days, it has fallen by -25.96%.
